The Pulse of Healthcare: Weight-Loss Drugs and Big Pharma Moves
Published on: May 1, 2026, 2:28 a.m. | Source: Devdiscourse
The latest health sector updates cover a range of topics: Eli Lilly's weight-loss drug Foundayo draws investor interest despite sales data unavailability, while Bristol Myers outperformed expectations with cancer drug sales. LEO Pharma is acquiring drug developer Replay, and the U.S. Supreme Court has sided with anti-abortion centers in a New Jersey case.
